BMI as a modifiable risk factor for type 2 diabetes: Refining and understanding causal estimates using mendelian randomization

Diabetes

Volumn 65, Issue 10, 2016, Pages 3002-3007

  Corbin, Laura J ^a   Richmond, Rebecca C ^a   Wade, Kaitlin H ^a   Burgess, Stephen ^a,b   Bowden, Jack ^a,c   Smith, George Davey ^a   Timpson, Nicholas J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; RISK FACTOR;

TCF7L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR 7 LIKE 2;

BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; ODDS RATIO; RISK FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84989171924     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0418     Document Type: Article

References (32)

1. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-1096
2. Holmes Michael V, Lange Leslie A, Palmer T, et al. Causal effects of body mass index on cardiometabolic traits and events: A Mendelian randomization analysis. Am J Hum Genet 2014;94:198-208
3. Davey Smith G, Hemani G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014;23:R89-R98
4. Davey Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22
5. Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163
6. Sleiman PMA, Grant SFA. Mendelian randomization in the era of genomewide association studies. Clin Chem 2010;56:723-728
7. Boef AGC, Dekkers OM, le Cessie S. Mendelian randomization studies: A review of the approaches used and the quality of reporting. Int J Epidemiol 2015; 44:496-511
8. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: Causal estimates from a Mendelian randomisation approach. PLoS Med 2012;9:e1001212
9. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44:512-525
10. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 2007;16:309-330
11. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016;40:304-314
12. Yaghootkar H, Frayling T. Recent progress in the use of genetics to understand links between type 2 diabetes and related metabolic traits. Genome Biol 2013;14:1-7
13. Dimas AS, Lagou V, Barker A, et al. Investigators obotM: Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014;63:2158-2171
14. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013;37: 658-665
15. Burgess S, Scott R, Timpson N, Davey Smith G, Thompson S. Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur J Epidemiol 2015;30:543-552
16. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: Subsample and 2-sample instrumental variable estimators. Am J Epidemiol 2013; 178:1177-1184
17. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015;518:197-206
18. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012;44:981-990
19. Team RC. R: A Language and Environment for Statistical Computing. 3.2.0 ed. Vienna, Austria, R Foundation for Statistical Computing, 2014
20. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
21. Bowden J. Assessing the Suitability of Summary Data for Mendelian Randomization Analyses Using MR-Egger Regression: The Role of the I2 Statistic. Technical Report (available on request). Bristol, U.K., University of Bristol, 2015
22. Stone M. Cross-validatory choice and assessment of statistical predictions. J R Stat Soc B 1974;36:111-147
23. Venables WN, Ripley BD. Modern Applied Statistics with S. New York, Springer, 2002
24. Fox J, Weisberg S. An R Companion to Applied Regression. Los Angeles, Sage, 2011
25. Cook RD. Detection of influential observation in linear regression. Technometrics 1977;19:15-18
26. Manning AK, Hivert M-F, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-669
27. Richmond RC, Davey Smith G, Ness AR, den Hoed M, McMahon G, Timpson NJ. Assessing causality in the association between child adiposity and physical activity levels: A Mendelian randomization analysis. PLoS Med 2014;11:e1001618
28. Taylor PN, Richmond R, Davies N, et al. Paradoxical relationship between body mass index and thyroid hormone levels: A study using Mendelian randomization. J Clin Endocrinol Metab 2016;101:730-738
29. Walter S, Kubzansky LD, Koenen KC, et al. Revisiting Mendelian randomization studies of the effect of body mass index on depression. Am J Med Genet B Neuropsychiatr Genet 2015;168:108-115
30. Office for National Statistics (UK). Statistical Bulletin: Annual Mid-year Population Estimates: 2013. Newport, U.K., Office For National Statistics, 2014
31. National Cardiovascular Intelligence Network. Cardiovascular disease key facts. In Diabetes: Public Health England. London, Public Health England, 2013
32. Gatineau M, Hancock C, Holman N, et al. Adult Obesity and Type 2 Diabetes. London, Public Health England, 2014